awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52668271-46E6C9C9-6580-4419-8DAC-2F6DAC0F8078
Q52668271-46E6C9C9-6580-4419-8DAC-2F6DAC0F8078
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52668271-46E6C9C9-6580-4419-8DAC-2F6DAC0F8078
Novel therapies for severe asthma in children and adults.
P2860
Q52668271-46E6C9C9-6580-4419-8DAC-2F6DAC0F8078
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52668271-46E6C9C9-6580-4419-8DAC-2F6DAC0F8078
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a18b0ae207a1082f14bbde3c1465f7ac0661eef3
P2860
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials.